Hormone Replacement Therapy Market Size, Share & Trends Report

Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Estrogen, Human Growth), By Route Of Administration (Oral, Parenteral), By Type Of Disease, By Region, And Segment Forecasts, 2020 - 2027

  • Published Date: Mar, 2020
  • Base Year for Estimate: 2019
  • Report ID: 978-1-68038-784-1
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2018
  • Number of Pages: 100

Table of Contents

Chapter Methodology and Scope
              1.1 Market Segmentation & Scope
                  1.1.1 Product
                  1.1.2 Route of Administration
                  1.1.3 Type of Disease
                  1.1.4 Regional Scope
              1.2 Research Methodology
              1.3 Information Procurement
                  1.3.1 Purchased Database
                  1.3.2 GVR’s Internal Database
                  1.3.3 Secondary Sources
                  1.3.4 Primary research
              1.4 Information or Data Analysis
                  1.4.1 Data Analysis Models
              1.5 Market Formulation & Validation
              1.6 Model Details
                  1.6.1 Commodity flow analysis (Model 1)
                  1.6.2 Volume price analysis (Model 2)
              1.7 List of Secondary Sources
              1.8 Objectives
                  1.8.1 Objective - 1
                  1.8.2 Objective - 2
Chapter 2 Executive Summary
              2.1 Market Outlook
              2.2 Segment Outlook
                  2.2.1 Product
                  2.2.2 Route of Administration
                  2.2.3 Type of Disease
                  2.2.4 Region
              2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
              3.1 Market Segmentation
              3.2 Penetration & Growth Prospect Mapping
                  3.2.1 Market Driver Analysis
                  3.2.2 Market Restraint Analysis
              3.3 Hormone Replacement Therapy Market: Business Environment Analysis Tools
                  3.3.1 Porter’s Five Forces Analysis
                      3.3.1.1 Bargaining power of suppliers
                      3.3.1.2 Bargaining power of buyers
                      3.3.1.3 Threat of new entrants
                      3.3.1.4 Competitive rivalry
                      3.3.1.5 Threat of substitutes
                  3.3.2 PESTEL Analysis
                      3.3.2.1 Political & legal
                      3.3.2.2 Economic
                      3.3.2.3 Technological
Chapter 4 Hormone Replacement Therapy Market: Product Analysis
              4.1 Hormone Replacement Therapy Product Market Share Analysis, 2019 & 2027
              4.2 Hormone Replacement Therapy Product Market: Segment Dashboard
              4.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Product Segment
                  4.3.1 Estrogen Hormone Replacement Therapy
                      4.3.1.1 Estrogen Hormone replacement therapy market, 2016 - 2027 (USD Million)
                  4.3.2 HGH Replacement Therapy
                      4.3.2.1 HGH replacement therapy market, 2016 - 2027 (USD Million)
                  4.3.3 Thyroid Hormone Replacement Therapy
                      4.3.3.1 Thyroid hormone replacement therapy market, 2016 - 2027 (USD Million)
                  4.3.4 Testosterone Hormone Replacement Therapy
                      4.3.4.1 Testosterone hormone replacement therapy market, 2016 - 2027 (USD Million)
Chapter 5 Hormone Replacement Therapy Market: Route of Administration Analysis
              5.1 Hormone Replacement Therapy Route of Administration Market Share Analysis, 2019 & 2027
              5.2 Hormone Replacement Therapy Route of Administration Market: Segment Dashboard
              5.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Route of Administration Segment
                  5.3.1 Oral
                      5.3.1.1 Oral market, 2016 - 2027 (USD Million)
                  5.3.2 Parenteral
                      5.3.2.1 Parenteral market, 2016 - 2027 (USD Million)
                  5.3.3 Transdermal
                      5.3.3.1 Transdermal market, 2016 - 2027 (USD Million)
                  5.3.4 Others
                      5.3.4.1 Others market, 2016 - 2027 (USD Million)
Chapter 6 Hormone Replacement Therapy Market: Type of Disease Analysis
              6.1 Hormone Replacement Therapy Type of Disease Market Share Analysis, 2019 & 2027
              6.2 Hormone Replacement Therapy Type of Disease Market: Segment Dashboard
              6.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Type of Disease Segment
                  6.3.1 Menopause
                      6.3.1.1 Menopause market, 2016 - 2027 (USD Million)
                  6.3.2 Hypothyroidism
                      6.3.2.1 Hypothyroidism market, 2016 - 2027 (USD Million)
                  6.3.3 Male Hypogonadism
                      6.3.3.1 Male hypogonadism market, 2016 - 2027 (USD Million)
                  6.3.4 Growth Hormone Deficiency
                      6.3.4.1 Growth hormone deficiency market, 2016 - 2027 (USD Million)
                  6.3.5 Others
                      6.3.5.1 Others market, 2016 - 2027 (USD Million)
Chapter 7 Hormone Replacement Therapy Market: Regional Analysis
              7.1 Hormone Replacement Therapy Regional Market Share Analysis, 2019 & 2027
              7.2 Hormone Replacement Therapy Regional Market: Segment Dashboard
              7.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
              7.4 Market Size, & Forecasts, and Trend Analysis, 2016 to 2027
                  7.4.1 North America
                      7.4.1.1 North America hormone replacement therapy market, 2016 - 2027 (USD Million)
                          7.4.1.1.1 U.S.
                              7.4.1.1.1.1 U.S. hormone replacement therapy market, 2016 - 2027 (USD Million)
                          7.4.1.1.2 Canada
                              7.4.1.1.2.1 Canada hormone replacement therapy market, 2016 - 2027 (USD Million)
                  7.4.2 Europe
                      7.4.2.1 Europe Hormone Replacement Therapy market, 2016 - 2027 (USD Million)
                          7.4.2.1.1 U.K.
                              7.4.2.1.1.1 U.K. hormone replacement therapy market, 2016 - 2027 (USD Million)
                          7.4.2.1.2 Germany
                              7.4.2.1.2.1 Germany hormone replacement therapy market, 2016 - 2027 (USD Million)
                  7.4.3 Asia Pacific
                      7.4.3.1 Asia Pacific hormone replacement therapy market, 2016 - 2027 (USD Million)
                          7.4.3.1.1 Japan
                              7.4.3.1.1.1 Japan hormone replacement therapy market, 2016 - 2027 (USD Million)
                          7.4.3.1.2 China
                              7.4.3.1.2.1 China hormone replacement therapy market, 2016 - 2027 (USD Million)
                  7.4.4 Latin America
                      7.4.4.1 Latin America hormone replacement therapy market, 2016 - 2027 (USD Million)
                          7.4.4.1.1 Brazil
                              7.4.4.1.1.1 Brazil hormone replacement therapy market, 2016 - 2027 (USD Million)
                          7.4.4.1.2 Mexico
                              7.4.4.1.2.1 Mexico hormone replacement therapy market, 2016 - 2027 (USD Million)
                  7.4.5 Middle East and Africa (MEA)
                      7.4.5.1 MEA hormone replacement therapy market, 2016 - 2027 (USD Million)
                          7.4.5.1.1 South Africa
                              7.4.5.1.1.1 South Africa hormone replacement therapy market, 2016 - 2027 (USD Million)
                          7.4.5.1.2 Saudi Arabia
                              7.4.5.1.2.1 Saudi Arabia hormone replacement therapy market, 2016 - 2027 (USD Million)
Chapter 8 Competitive Analysis
              8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
              8.2 Vendor Landscape
              8.3 Company market position analysis (Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
              8.4 Company Profiles
                  8.4.1 Abbott Laboratories
                      8.4.1.1 Company overview
                      8.4.1.2 Financial performance
                      8.4.1.3 Product benchmarking
                      8.4.1.4 Strategic initiatives
                  8.4.2 Novartis
                      8.4.2.1 Company overview
                      8.4.2.2 Financial performance
                      8.4.2.3 Product benchmarking
                      8.4.2.4 Strategic initiatives
                  8.4.3 Pfizer
                      8.4.3.1 Company overview
                      8.4.3.2 Financial performance
                      8.4.3.3 Product benchmarking
                      8.4.3.4 Strategic initiatives
                  8.4.4 Mylan Laboratories
                      8.4.4.1 Company overview
                      8.4.4.2 Financial performance
                      8.4.4.3 Product benchmarking
                      8.4.4.4 Strategic initiatives
                  8.4.5 Merck & Co.
                      8.4.5.1 Company overview
                      8.4.5.2 Financial performance
                      8.4.5.3 Product benchmarking
                      8.4.5.4 Strategic initiatives
                  8.4.6 Amgen
                      8.4.6.1 Company overview
                      8.4.6.2 Financial performance
                      8.4.6.3 Product benchmarking
                      8.4.6.4 Strategic initiatives
                  8.4.7 Novo Nordisk
                      8.4.7.1 Company overview
                      8.4.7.2 Financial performance
                      8.4.7.3 Product benchmarking
                      8.4.7.4 Strategic initiatives
                  8.4.8 Bayer
                      8.4.8.1 Company overview
                      8.4.8.2 Financial performance
                      8.4.8.3 Product benchmarking
                      8.4.8.4 Strategic initiatives
                  8.4.9 Eli Lilly
                      8.4.9.1 Company overview
                      8.4.9.2 Financial performance
                      8.4.9.3 Product benchmarking
                      8.4.9.4 Strategic initiatives
                  8.4.10 Genentech
                      8.4.10.1 Company overview
                      8.4.10.2 Financial performance
                      8.4.10.3 Product benchmarking
                      8.4.10.4 Strategic initiatives


List of Tables

TABLE 1 List of secondary sources
TABLE 2 North America hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
TABLE 3 North America hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 4 North America hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 5 North America hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 6 U.S. hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 7 U.S. hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 8 U.S. hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 9 Canada hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 10 Canada hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 11 Canada hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 12 Europe hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
TABLE 13 Europe hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 14 Europe hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 15 Europe hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 16 U.K. hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 17 U.K. hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 18 U.K. hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 19 Germany hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 20 Germany hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 21 Germany hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 22 Asia Pacific hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
TABLE 23 Asia Pacific hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 24 Asia Pacific hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 25 Asia Pacific hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 26 Japan hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 27 Japan hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 28 Japan hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 29 China hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 30 China hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 31 China hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 32 Latin America hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
TABLE 33 Latin America hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 34 Latin America hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 35 Latin America hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 36 Brazil hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 37 Brazil hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 38 Brazil hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 39 Mexico hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 40 Mexico hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 41 Mexicohormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 42 MEA hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
TABLE 43 MEA hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 44 MEA hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 45 MEA hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 46 South Africa hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 47 South Africa hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 48 South Africa hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 49 Saudi Arabia hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 50 Saudi Arabia hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 51 Saudi Arabia hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Hormone replacement therapy market outlook, 2019
FIG. 9 Market trends & outlook
FIG. 10 Hormone replacement therapy market segmentation
FIG. 11 Penetration & growth prospect mapping
FIG. 12 Market driver relevance analysis (Current & future impact)
FIG. 13 Market restraint relevance analysis (Current & future impact)
FIG. 14 Global hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 15 Hormone replacement therapy: Market dynamics
FIG. 16 Global geriatric population, 2012 - 2022 (Million)
FIG. 17 Percentage of geriatric population in European countries, 2014
FIG. 18 Opportunity analysis, by product
FIG. 19 Hormone replacement therapy market - Porter’s analysis
FIG. 20 Hormone replacement therapy market - PESTEL analysis
FIG. 21 Global hormone replacement therapy market share, by product, 2016 & 2027
FIG. 22 Estrogen hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 23 Human growth hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 24 Thyroid hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 25 Testosterone hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 26 Global hormone replacement therapy market share, by route of administration, 2016 & 2027
FIG. 27 Oral hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 28 Parenteral hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 29 Transdermal hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 30 Other route of administration hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 31 Global hormone replacement therapy market share, by type of disease, 2016 & 2027
FIG. 32 Menopause market, 2016 - 2027 (USD Million)
FIG. 33 Hypothyroidism market, 2016 - 2027 (USD Million)
FIG. 34 Male hypogonadism market, 2016 - 2027 (USD Million)
FIG. 35 Growth hormone deficiency market, 2016 - 2027 (USD Million)
FIG. 36 Others market, 2016 - 2027 (USD Million)
FIG. 37 Hormone replacement therapy market share, by region, 2016 & 2027
FIG. 38 North America hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 39 U.S. hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 40 Canada hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 41 Europe hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 42 U.K. hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 43 Germany hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 44 Asia Pacific hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 45 Japan hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 46 China hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 47 Latin America hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 48 Brazil hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 49 Mexico hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 50 MEA hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 51 South Africa hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 52 Saudi Arabia hormone replacement therapy market, 2016 - 2027 (USD Million)
FIG. 53 Strategy framework
FIG. 54 Hormone replacement therapy competitive landscape: Market position analysis (based on products, regional presence, and recent updates (2019))

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.